J&J in talks with Centre for trial of single-shot Covid-19 vaccine

Russia's Sputnik V is another contender to get approval from the Indian drug regulator

US major Johnson and Johnson (J&J) has initiated talks with the Centre to start clinical trials of its single-shot Covid-19 vaccine in India.
 
This comes at a time when the country is grappling with adequate vaccine supplies to meet its national Covid-19 vaccination programme.
 
A J&J India spokesperson said: “At J&J, we remain fully focused on bringing a safe and effective Covid-19 vaccine to people around the world, if authorised for use by local health authorities. We are in discussions with the Government of India with the objective of starting clinical study of our Janssen Covid-19 vaccine candidate